These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32685291)

  • 1. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
    Chand GB; Banerjee A; Azad GK
    PeerJ; 2020; 8():e9492. PubMed ID: 32685291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.
    Yashvardhini N; Jha DK; Bhattacharya S
    Arch Microbiol; 2021 Nov; 203(9):5463-5473. PubMed ID: 34410443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of recurrent mutations in exonuclease (nsp14); a potential drug target in SARS-CoV-2.
    Jha DK; Yashvardhini N; Kumar A
    Indian J Pathol Microbiol; 2021; 64(4):771-775. PubMed ID: 34673601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging genetic diversity of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) alters its B-cell epitopes.
    Kumar S; Kumari K; Azad GK
    Biologicals; 2022 Jan; 75():29-36. PubMed ID: 34802866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
    Banerjee A; Sarkar R; Mitra S; Lo M; Dutta S; Chawla-Sarkar M
    JMIR Bioinform Biotechnol; 2020; 1(1):e20735. PubMed ID: 33496683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.
    Mari A; Roloff T; Stange M; Søgaard KK; Asllanaj E; Tauriello G; Alexander LT; Schweitzer M; Leuzinger K; Gensch A; Martinez AE; Bielicki J; Pargger H; Siegemund M; Nickel CH; Bingisser R; Osthoff M; Bassetti S; Sendi P; Battegay M; Marzolini C; Seth-Smith HMB; Schwede T; Hirsch HH; Egli A
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34069681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
    Chand GB; Banerjee A; Azad GK
    Gene Rep; 2020 Dec; 21():100891. PubMed ID: 33015411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
    Biswas SK; Mudi SR
    Genomics Inform; 2020 Dec; 18(4):e44. PubMed ID: 33412760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.
    Hartley PD; Tillett RL; AuCoin DP; Sevinsky JR; Xu Y; Gorzalski A; Pandori M; Buttery E; Hansen H; Picker MA; Rossetto CC; Verma SC
    medRxiv; 2020 Oct; ():. PubMed ID: 32869037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
    Azad GK
    Biochem Biophys Rep; 2020 Dec; 24():100833. PubMed ID: 33072893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2.
    Mallick Gupta A; Mandal S; Mandal S; Chakrabarti J
    J Biomol Struct Dyn; 2023 May; 41(8):3542-3552. PubMed ID: 35293850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation.
    Yang S; Multani A; Garrigues JM; Oh MS; Hemarajata P; Burleson T; Green NM; Oliai C; Gaynor PT; Beaird OE; Winston DJ; Seet CS; Schaenman JM
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An
    Alexpandi R; De Mesquita JF; Pandian SK; Ravi AV
    Front Microbiol; 2020; 11():1796. PubMed ID: 32793181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Mutations on the Pathogenic and Antigenic Activity of SARS-CoV-2 during the First Wave of the COVID-19 Pandemic: A Comprehensive Immunoinformatics Analysis.
    Baloch Z; Ikram A; Hakim MS; Awan FM
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated analysis of variations in SARS-CoV-2 genome.
    Ugurel OM; Ata O; Turgut-Balik D
    Turk J Biol; 2020; 44(3):157-167. PubMed ID: 32595352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of coronaviruses in
    Yadav PD; Shete-Aich A; Nyayanit DA; Pardeshi P; Majumdar T; Balasubramanian R; Ullas PT; Mohandas S; Dighe H; Sawant P; Patil S; Patil D; Gokhale MD; Mathapati B; Sudeep AB; Baradkar S; Kumar A; Kharde R; Salve M; Joshi Y; Gupta N; Mourya DT
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):226-235. PubMed ID: 32317409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
    Khan MA; Sany MRU; Islam MS; Islam ABMMK
    Front Genet; 2020; 11():765. PubMed ID: 32765592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RdRp mutations are associated with SARS-CoV-2 genome evolution.
    Eskier D; Karakülah G; Suner A; Oktay Y
    PeerJ; 2020; 8():e9587. PubMed ID: 32742818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.
    Eskier D; Suner A; Oktay Y; Karakülah G
    PeerJ; 2020; 8():e10181. PubMed ID: 33083157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance.
    Padhi AK; Shukla R; Saudagar P; Tripathi T
    iScience; 2021 Jan; 24(1):101992. PubMed ID: 33490902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.